Quisitive Collaborates with Heart-Tech Health for Cardiac Health Innovation
15 Agosto 2023 - 7:30AM
Quisitive Technology Solutions, Inc.
(“
Quisitive” or the “
Company”)
(
TSXV: QUIS, OTCQX: QUISF), a premier Microsoft
solutions provider and payments solutions provider, has partnered
with Heart-Tech Health to implement MazikCare as an Integrated Care
Delivery tool to prevent women’s heart disease.
Founded by NY Times Super Doctor and preventative cardiologist
Dr. Suzanne Steinbaum, Heart-Tech Health has created Adesso, a
first-of-its-kind cardiac preventative care platform aimed at
reducing women’s heart disease. Heart-Tech Health strives to
provide clients with trusted information, empower women’s
self-advocacy in healthcare, and provide lifestyle intervention
pathways.
Quisitive has partnered with Heart-Tech Health
to implement its MazikCare Care Path solution within Adesso to
empower patients and providers to collaborate on comprehensive care
plans by facilitating the seamless transfer of information between
care teams and creating pathways from risk identification to proven
interventions. The solution will enable patients to access
lifestyle and diagnostic screenings, view recommended lifestyle
changes that create true health impact, and efficiently connect to
providers to improve health outcomes. The value-based care platform
will help eliminate unnecessary testing and reduce ER visits and
hospitalizations, decreasing overall spending on heart-related
health matters.
MazikCare, built by leveraging the Microsoft Power Platform,
delivers digital transformation in both legacy and underserviced
markets. This initial roll-out of the Adesso SaaS platform and
MazikCare software will support 3,500 patient users.
“The partnership with Quisitive is critical in realizing our
vision for improved cardiovascular health for women worldwide,”
said CEO and Founder of Heart-Tech Health, Dr. Suzanne Steinbaum.
“80% of heart disease is preventable, and yet our health system
spends in abundance of $194 billion annually to treat women’s heart
disease. The MazikCare platform provides the technological tools
necessary to enable broad access to diagnostic screenings,
heart-health information, and clear care pathways to improve
women’s cardiac health, reduce costs, and ultimately, save
lives.”
“We designed the Quisitive MazikCare platform to be easily
implemented across every medical specialty and patient demographic
to better connect patients to quality care,” added Quisitive CEO
Mike Reinhart. “Now, we are continuing to expand MazikCare's impact
through our partnership with Heart-Tech Health to address the
leading cause of death for women in the United States, heart
disease. We are proud to be partnering with Dr. Steinbaum and her
team to positively impact women’s health outcomes.”
About Quistive:
Quisitive (TSXV: QUIS, OTCQX: QUISF) is a premier, global
Microsoft partner that harnesses the Microsoft cloud platform and
complementary technologies, including custom solutions and
first-party offerings, to generate transformational impact for
enterprise customers. Our Cloud Solutions business focuses on
helping enterprises move, operate, and innovate in the three
Microsoft clouds. Our Payments Solutions division leverages the
PayiQ platform powered by Microsoft Azure to transform the payment
processing industry into an entirely new source of customer
engagement and consumer value. Quisitive serves clients globally
from seventeen employee hubs across the world. For more
information, visit www.Quisitive.com and follow @BeQuisitive.
About Heart-Tech Health:
Heart-Tech Health created Adesso, a SaaS suite developed by one
of the nation’s leading preventative cardiologists. Adesso
identifies cardiac risk earlier through its proprietary,
comprehensive risk assessment and treats cardiac disease through
its fully insured personalized health and wellness programs that
improves access to care for all women. Adesso is offered through
Insurers, Corporate Wellness Programs and Value-Based Medical
Providers and generates tremendous cost savings. The Adesso suite
includes the “Addesso Heart Score” used by women to discover their
heart risk, and “MyAdesso,” which creates and tracks their
personalized prevention journey, ensures compliance, encourages
behavioral change through tracking and remote patient monitoring.
It also allows them to be more effective advocates for proper
testing and medical care. For Providers, the “Adesso Clinical
Portal” closely tracks data and offers them a more efficient way to
ensure greater outcomes and needed behavior change cooperatively
with their patients, through a medically validated personalized
prevention strategy. Adesso is the most comprehensive,
cost-effective solution for women’s heart health which is
transforming how cardiological prevention is being
offered.
Quisitive Investor ContactMatt Glover and John
YiGateway Investor RelationsQUIS@gateway-grp.com949-574-3860
Quisitive Management ContactTami AndersChief of
Stafftami.anders@quisitive.com
Quisitive Technology Sol... (TSXV:QUIS)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Quisitive Technology Sol... (TSXV:QUIS)
Gráfica de Acción Histórica
De May 2023 a May 2024